TITLE:
Investigational Drug Versus an Approved Drug in Patients With Rheumatoid Arthritis (0663-072)

CONDITION:
Rheumatoid Arthritis

INTERVENTION:
MK0663, etoricoxib

SUMMARY:

      The purpose of this study is to evaluate the long-term safety of an investigational drug
      versus an approved drug for the relief of pain in patients with rheumatoid arthritis.
    

DETAILED DESCRIPTION:

      The duration of treatment is 12 months.
    

ELIGIBILITY:
Gender: All
Age: 50 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Males and females 50 years or older with rheumatoid arthritis.

        Exclusion Criteria:

          -  History of gastrointestinal malabsorption or inflammatory bowel disease

          -  History of heart problems such as: congestive heart failure (CHF), heart attack or
             high blood pressure.
      
